CMC·HCI structure
|
Common Name | CMC·HCI | ||
---|---|---|---|---|
CAS Number | 51391-96-9 | Molecular Weight | 275.69 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C10H14ClN3O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CMC·HCI5-Methylcyclocytidine hydrochloride is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 2-(hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-ol,hydrochloride |
---|---|
Synonym | More Synonyms |
Description | 5-Methylcyclocytidine hydrochloride is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C10H14ClN3O4 |
---|---|
Molecular Weight | 275.69 |
Exact Mass | 275.06700 |
PSA | 100.59000 |
Storage condition | 2~8 ℃ |
Hazard Codes | Xn |
---|
I07-0083 |
6H-Furo[2',3':4,5]oxazolo[3,2]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-7-methyl-,monohydrochloride,[2R-(2a,3b,3ab)]-(9Cl) |